Twitter

Link your Twitter Account to Market Wire News

When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.

Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / REGN - Regeneron to buy 23andMe for $256M in court-supervised sale

REGN - Regeneron to buy 23andMe for $256M in court-supervised sale

May, 19 2025 07:32 AM Regeneron Pharmaceuticals Inc.

2025-05-19 07:32:26 ET

More on Regeneron Pharmaceuticals

Regeneron Pharmaceuticals, Inc. (REGN) BofA Securities 2025 Healthcare Conference (Transcript)
Regeneron Continues To Regenerate Its Drug Pipeline, While Keeping Leverage Down
Regeneron Pharmaceuticals, Inc. (REGN) Q1 2025 Earnings Call Transcript
Notable analyst calls this week: Caterpillar, UnitedHealth and Peloton among top picks
Regeneron wins over $400M jury award as Amgen found liable in antitrust case

For further details see:

Regeneron to buy 23andMe for $256M in court-supervised sale

Stock Information

Company Name:	Regeneron Pharmaceuticals Inc.
Stock Symbol:	REGN
Market:	NASDAQ
Website:	regeneron.com

REGN REGN Quote REGN Short REGN News REGN Articles REGN Message Board

Get REGN Alerts

News, Short Squeeze, Breakout and More Instantly...

Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.